Simran Kaur
Impact in
- Periodontics top 10%
- Scientific and Engineering Research Topics
- Pharmaceutical Science top 10%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
Papers in
-
- Lipid Membrane Structure and Behavior 2
-
- Drug Solubulity and Delivery Systems 3
- Advanced Drug Delivery Systems 3
- Advancements in Transdermal Drug Delivery 2
- Co-authors
- Dinesh Kumar Chellappan (2 shared papers)Murtaza M. Tambuwala (2 shared papers)Harjeet Singh (1 shared paper)Hamid A. Bakshi (1 shared paper)Gaurav Gupta (1 shared paper)Meenu Mehta (1 shared paper)Kamal Dua (1 shared paper)Parvarish Sharma (1 shared paper)
- Journals
- Cancer Letters (2 papers)Journal of Pharmaceutical Investigation (1 paper)Planta (1 paper)Organic Letters (1 paper)Environmental Monitoring and Assessment (1 paper)
- Partner nations
- IndiaUnited StatesMalaysia
In The Last Decade
Simran Kaur
27 papers receiving 513 citations
Peers
Comparison fields: 5 of 130
- Periodontics 40
- Pharmaceutical Science 48
- Biomaterials 88
- Molecular Medicine 18
- Biotechnology 23
Countries citing papers authored by Simran Kaur
This map shows the geographic impact of Simran Kaur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simran Kaur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simran Kaur more than expected).
Fields of papers citing papers by Simran Kaur
This network shows the impact of papers produced by Simran Kaur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simran Kaur. The network helps show where Simran Kaur may publish in the future.
Co-authors
The 25 scholars most cited alongside Simran Kaur, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 253 | |
| 2 | 2023 | 41 | |
| 3 | 2015 | 28 | |
| 4 | 2021 | 26 | |
| 5 | 2023 | 24 | |
| 6 | 2024 | 20 | |
| 7 | 2015 | 18 | |
| 8 | 2021 | 17 | |
| 9 | 2023 | 15 | |
| 10 | 2018 | 13 | |
| 11 | 2013 | 13 | |
| 12 | 2023 | 12 | |
| 13 | 2022 | 11 | |
| 14 | Immunohistochemical co-expression of c-erbb-2/Neu oncoprotein, altered tumour suppressor (p53) protein, EGF-R and EMA in histological subtypes of infiltrating duct carcinoma of the breast. | 1999 | 9 |
| 15 | 2024 | 9 | |
| 16 | 1990 | 7 | |
| 17 | 2020 | 7 | |
| 18 | 2023 | 5 | |
| 19 | Formulation and Characterization of Chewable Tablets of Paracetamol and Metoclopramide Hydrochloride | 2014 | 4 |
| 20 | 2025 | 4 |
About Simran Kaur
Simran Kaur is a scholar working on Molecular Biology, Pharmaceutical Science, Oncology, Biomaterials and Organic Chemistry, having authored 33 papers that have together received 547 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (3 papers), Drug Solubulity and Delivery Systems (3 papers), Advanced Drug Delivery Systems (3 papers), Immunotherapy and Immune Responses (2 papers), Advancements in Transdermal Drug Delivery (2 papers), Lipid Membrane Structure and Behavior (2 papers), Infection Control and Ventilation (1 paper) and Nanoplatforms for cancer theranostics (1 paper). The work is most often cited by research in Periodontics (40 citations), Pharmaceutical Science (48 citations), Biomaterials (88 citations), Molecular Medicine (18 citations) and Biotechnology (23 citations). Simran Kaur has collaborated with scholars based in India, United States and Malaysia. Frequent co-authors include Dinesh Kumar Chellappan, Murtaza M. Tambuwala, Harjeet Singh, Hamid A. Bakshi, Gaurav Gupta, Meenu Mehta, Kamal Dua, Parvarish Sharma, S. Rajeshkumar and Saurabh Satija. Their work appears in journals such as Cancer Letters, Journal of Pharmaceutical Investigation, Planta, Organic Letters and Environmental Monitoring and Assessment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.